Transform Chronic Disease Control
Patients
Patients benefit from MedsEngine’s augmentation of their provider’s clinical decision-making by getting under control in fewer visits and having less long-term damage from their chronic diseases. They can feel more confident with a focused, personalized treatment recommendation and are more engaged in their healthcare, ultimately leading to longer, healthier lives.
Providers and Healthcare Systems
MedsEngine quickly retrieves the pertinent EHR clinical information necessary for providers to make fully informed decisions in the care of their patients who have chronic diseases and displays it all on one screen. A quick glance is all that is needed to verify the information and proceed to personalized, evidence-based and guideline directed therapeutic recommendations.
MedsEngine saves time in the visit by eliminating all the clicks through the EHR tabs and in the future by getting the patients in control more quickly. More time allows the provider to focus on the patient’s other issues and accept more patients into the practice.
Providers in capitated plans and value-based contracts can benefit substantially from quicker control of patients with chronic disease by fewer office visits and fewer high-cost emergency department and hospital admissions.
Healthcare systems can benefit from MedsEngine’s evidence-based treatment and follow-up recommendations for more consistent management and control of patients with chronic disease. Physicians and advanced practice providers can deliver the same high-quality care, allowing for expanded patient panels and fewer costly 30-day readmissions.
Self-Insured Employers
Managing health care costs is critical for every business, large or small. Companies that self-insure have direct access to employee health claims data and can utilize this information to focus on the specific healthcare needs of their employees. It is imperative that employees receive personalized, evidence-based treatment recommendations to prevent the debilitating, high-cost outcomes of uncontrolled hypertension, type 2 diabetes, and elevated cholesterol. MedsEngine empowers healthcare providers of self-funded companies to control these chronic diseases effectively, leading to healthier and more productive workforces while reducing healthcare costs.
Medicare / Medicaid
According to CMS data for 2022, Medicare spent $944 billion, and Medicaid spent $805 billion for healthcare for Americans.1 The CDC reports 90% of the nation’s $4.5 trillion in annual healthcare expenditures are for people with chronic and mental health conditions.2 Using MedsEngine, two medical groups have achieved nearly twice the national average control rate for hypertension. And it is widely known and accepted that controlling hypertension decreases the incidence of stroke, heart disease, and kidney failure. Controlling chronic disease now will avoid the need to treat the much more expensive complications later.
Medicare Advantage Insurance Providers
The lower than anticipated announcement of the final 2025 rates for Medicare Advantage (MA) payments by the government triggered worries about a margin squeeze. Insurers faced with higher medical costs can benefit greatly from controlling chronic disease. Data from 2014 – 2019 show that the average cost of one hospitalization for HFrEF was $14,690.3 Expenditures for stroke for that period were $140,048 (direct + indirect)4 per event, totaling more than $100 billion annually for both conditions.
VA and Federally Qualified Health Centers
Our veterans and underserved populations deserve high-quality health care. MedsEngine for chronic disease control provides evidence-based recommendations allowing for continuity of care for patients who use healthcare centers that often have rotating providers. Controlling chronic disease results in healthier patients, fewer preventable hospitalizations, and billions of dollars in savings.
1 https://www.cms.gov/files/document/highlights.pdf
2 https://www.cdc.gov/chronic-disease/data-research/facts-stats/
3 Katherine M Osenenko , Effie Kuti, Alison M Deighton, Pratik Pimple, Shelagh M Szabo; doi: 10.18553/jmcp.2022.28.2.157
4 Rochmah, T.N.; Rahmawati, I.T.; Dahlui, M.; Budiarto, W.; Bilqis, N. Economic Burden of Stroke Disease: A Systematic Review. Int. J. Environ. Res. Public Health 2021, 18, 7552. https://doi.org/10.3390/ijerph18147552
Contact us to learn more about what MedsEngine can do for you.
